Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;183(5):829-830.
doi: 10.1111/bjd.18901. Epub 2020 Mar 5.

Ligelizumab for chronic spontaneous urticaria

R A Sabroe  1
Affiliations

Ligelizumab for chronic spontaneous urticaria

R A Sabroe. Br J Dermatol. 2020 Nov.
No abstract available

PubMed Disclaimer

References

    1. Zuberbier T, Aberer W, Asero R et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy 2018; 73:1393-414.
    1. Powell RJ, Leech SC, Till S et al. BSACI guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy 2015; 45:547-65.
    1. Maurer M, Gimenez-Arnau AM, Sussman G et al. Ligelizumab for chronic spontaneous urticaria. N Engl J Med 2019; 381:1321-32.
    1. Gauvreau GM, Arm JP, Boulet L-P et al. Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses. J Allergy Clin Immunol 2016; 138:1051-9.
    1. Kolkhir P, Church MK, Weller K et al. Autoimmune chronic spontaneous urticaria: what we know and what we do not know. J Allergy Clin Immunol 2017; 139:1772-81.